Assessment of anti-cyclic citrullinated peptide in psoriatic arthritis

BMC Research Notes

Volumn 2, Issue , 2009, Pages

  Abdel Fattah, Nermeen Sa ^a   Hassan, Hanan E ^a   Galal, Zenab A ^a   El Okda, El Sayed E ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77049122756     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-2-44     Document Type: Article

References (27)

1. Progression of peripheral joint disease in psoriatic arthritis: a 5-yr prospective study. NJ McHugh C Balachrishnan SM Jones, Rheumatology Oxford 2003 42 778 783 10.1093/rheumatology/keg217 12730539
2. Rheumatoid arthritis or psoriatic symmetric polyarthritis? A difficult differential diagnosis. C Palazzi I Olivieri A Petricca C Salvarani, Clin Exp Rheumatol 2002 20 3 4 11892705
3. Relationship of psoriatic arthritis with the other spondyloarthropathies. PS Helliwell, Curr Opin Rheumatol 2004 16 344 349 10.1097/01.bor.0000129717. 19777.9d 15201595
4. Classification and diagnostic criteria for psoriatic arthritis. PS Helliwell WJ Taylor, Ann Rheum Dis 2005 64 Suppl 2 i3 ii8 15708931 10.1136/ard.2004.032318 (Pubitemid 40288511)
5. Psoriatic arthritis. JMH Moll V Wright, Semin Arthritis Rheum 1973 3 55 78 Quoted from: (4) 10.1016/0049-0172(73)90035-8 4581554
6. Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value. MAM van Boekel ER Vossenaar FHJ van den Hoogen WJ van Venrooij, Arthritis Res 2002 4 87 93 11879544 10.1186/ar395 (Pubitemid 34257342)
7. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. GA Schellekens H Visser BAW de Jong, Arthritis Rheum 2000 43 155 163 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0. CO;2-3 10643712
8. Anti-cyclic citrullinated peptide antibodies, IgM and IgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis. S Bas S Genevay O Meyer C Gabay, Rheumatology (Oxford) 2003 42 5 677 680 10.1093/rheumatology/ keg184 12709545
9. Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis. N Bizzaro G Mazzanti E Tonutti D Villalta R Tozzoli, Clin Chem 2001 47 1089 1093 11375296
10. The prognostic value of anti-cyclic citrullinated peptide antibodies in patients with recent-onset rheumatoid arthritis. E Krott BAW de Jong MA van Leeuwen, Arthritis Rheum 2000 43 1831 1835 10.1002/1529-0131(200008)43: 8<1831::AID-ANR19>3.0.CO;2-6 10943873
11. Anti-citrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five years radiographic damage. O Meyer C Labarre M Dougados, Ann Rheum Dis 2003 62 120 126 12525380 10.1136/ard.62.2.120 (Pubitemid 36135386)
12. Antibodies against cyclic citrullinated peptide (CCP) in psoriatic patients with or without joint inflammation. GM Alenius E Berglin SR Dahlqvist, Ann Rheum Dis 2006 65 398 400 16096328 10.1136/ard.2005.040998 (Pubitemid 43268233)
13. Low frequency of anticyclic citrullinated peptide antibodies in psoriatic arthritis but not in cutaneous psoriasis. L Candia J Marquez C Gonzalez AM Santos J Londono R Valle J Zabaleta Z Yaqub LR Espinoza, J Clin Rheumatol 2006 12 226 229 10.1097/rhu.0000242779.73390.51 17023808
14. Antibodies to cyclic citrullinated peptides in psoriatic arthritis. L Bogliolo C Alpini R Caporali CA Scire R Moratti C Montecucco, J Rheumatol 2005 32 511 515 15742445
15. Anti-citrullinated peptide antibodies may occur in patients with psoriatic arthritis. B Vander Cruyssen IE Hoffman H Zmierczak M Van den Berghe E Kruithof L De Rycke, Ann Rheum Dis 2005 64 1145 1149 15695535 10.1136/ard.2004.032177 (Pubitemid 41113348)
16. The clinical and genetic associations of anti-cyclic citrullinated peptide antibodies in psoriatic arthritis. E Korendowych P Owen J Ravindran C Carmichael N McHugh, Rheumatology (Oxford) 2005 44 1056 1060 10.1093/rheumatology/keh686 15901902
17. Anti-CCP antibodies in rheumatoid arthritis and psoriatic arthritis. N Inanc E Dalkilic S Kamali E Kasapoglu-Gunal Y Elbir H Direskeneli M Inanc, Clin Rheumatol 2007 26 17 23 10.1007/s10067-006-0214-5 16538391
18. Antibodies to cyclic citrullinated peptides in patients with psoriatic arthritis. NSA Abdel Fattah HE Hassan ZA Galal, Egypt J Dermatol Venereol 2008 28 13 23
19. Psoriatic arthritis: clinical and laboratory analysis of 220 patients. D Gladmann R Shuckett ML Russell JC Thorne RK Schachter, Q J Med 1987 62 127 141 3659255
20. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. FC Arnett SM Edworthy DA Bloch DJ McShane JF Fries NS Cooper, Arthritis Rheum 1998 31 3 315 324 10.1002/art.1780310302
21. The psoriasis area and severity index is the adequate criteria to define severity in chronic plaque-type psoriasis. J Schmitt G Wozel, Dermatol 2005 210 194 199 10.1159/000083509 (Pubitemid 40529233)
22. Mixed cryoglobulinemia and chronic hepatitis C infection: the rheumatic manifestations. N Leone R Pellicano I Ariata-Maiocco, J Med Virol 2002 66 200 203 10.1002/jmv.2130 11782928
23. The relation between class-specific serum rheumatoid factors and age in the general population. D van Schaardenburg AM Lagaay HG Otten FC Breedveld, Br J Rheumatol 1993 32 546 549 10.1093/rheumatology/32.7.546 8339123
24. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. S Rantapaa-Dahlqvist BA de Jong E Berglin G Hallmans G Wadell H Stenlund, Arthritis Rheum 2003 48 2741 2749 10.1002/art.11223 14558078
25. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. MM Nielen D van Schaardenburg HW Reesink RJ van de Stadt IE van der Horst-Bruinsma MH de Koning, Arthritis Rheum 2004 50 380 386 10.1002/art.20018 14872479
26. Current concepts and new developments in the treatment of psoriatic arthritis. N Pipitone GH Kingsley A Manzo DL Scott C Pitzalis, Rheumatology 2003 42 1138 1148 10.1093/rheumatology/keg363 12810935
27. Serological changes following B lymphocytes depletion therapy for rheumatoid arthritis. G Cambridge MJ Leandro JC Edward, Arthritis Rheum 2003 48 2146 2154 10.1002/art.11181 12905467